Our Terms & Conditions | Our Privacy Policy
(Photo by Pyotr Kovalev/TASS)
MOSCOW – Imuron-vac, a Russian vaccine for immunotherapy of bladder cancer, developed by the Gamaleya National Center of Epidemiology and Microbiology, has been registered by the Russian Health Ministry and is being used for post-surgery treatment of patients, the center’s Director Alexander Gintsburg told TASS.
“Yes, it has been registered… And it is being successfully used for immunotherapy after surgical treatment of bladder cancer,” he said.
READ:
More than 170,000 COVID vaccines wasted in Central Visayas
DOH: COVID vaccines remain effective vs new variant
In his words, the bladder cancer vaccine is also being exported to countries of the Commonwealth of Independent States, where it is in great demand.
The delivery of a large batch of the medicine to Armenia is now being planned.
The scientist went on to say that the trials of the vaccine have been successfully completed, returning valuable data. (TASS)
Your subscription could not be saved. Please try again.
Your subscription has been successful.
Read Next
Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.
Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.
Aggregated From –
Comments are closed.